|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | |
| A61K 31/437 | |||
| A61P 7/00 | |||
| C07D 401/14 | |||
| C07D 401/04 | |||
| C07C 65/30 | |||
| C07D 231/56 | |||
| C07D 471/04 | |||
| C07D 257/04 | |||
| C07D 211/62 | |||
| C07D 213/30 | |||
| C07D 401/12 | |||
| C07D 213/64 | |||
| C07D 403/12 | |||
| C07D 265/30 | |||
| C07D 207/08 | |||
| C07D 211/30 |
| (11) | Number of the document | 2970196 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14770695.6 |
| Date of filing the European patent application | 2014-03-10 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/022769 |
| Date | 2014-03-10 |
| (87) | Number | WO 2014/150268 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201313815735 | 2013-03-15 | US | |
| 201361905803 P | 2013-11-18 | US |
| (72) |
XU, Qing, US
LI, Zhe, US
GWALTNEY II, Stephen L., US
|
| (73) |
Global Blood Therapeutics, Inc.,
181 Oyster Point Blvd., South San Francisco, CA 94080,
US
|
| (54) | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN |
| COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN |